Fluoroquinolone Amorphous Polymeric Salts and Dispersions for Veterinary Uses
Enrofloxacin (ENRO) is a poorly soluble drug used in veterinary medicine. It differs from the more widely used fluoroquinolone ciprofloxacin (CIP) by the presence of an ethyl substituent on its piperazine amino group. While a number of recent studies have examined amorphous composite formulations of...
Saved in:
Main Authors: | Hanah Mesallati (Author), Anita Umerska (Author), Lidia Tajber (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2019-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Advances in the development of amorphous solid dispersions: The role of polymeric carriers
by: Jie Zhang, et al.
Published: (2023) -
Polymeric Amorphous Solid Dispersions of Dasatinib: Formulation and Ecotoxicological Assessment
by: Katarina Sokač, et al.
Published: (2024) -
Application of a Physiologically Based Pharmacokinetic Model to Develop a Veterinary Amorphous Enrofloxacin Solid Dispersion
by: Kaixiang Zhou, et al.
Published: (2021) -
Drug crystal growth in ternary amorphous solid dispersions: Effect of surfactants and polymeric matrix-carriers
by: Afroditi Kapourani, et al.
Published: (2021) -
Sweeteners Show a Plasticizing Effect on PVP K30-A Solution for the Hot-Melt Extrusion of Fixed-Dose Amorphous Curcumin-Hesperetin Solid Dispersions
by: Kamil Wdowiak, et al.
Published: (2024)